340 related articles for article (PubMed ID: 21841782)
1. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis.
Matmati M; Jacques P; Maelfait J; Verheugen E; Kool M; Sze M; Geboes L; Louagie E; Mc Guire C; Vereecke L; Chu Y; Boon L; Staelens S; Matthys P; Lambrecht BN; Schmidt-Supprian M; Pasparakis M; Elewaut D; Beyaert R; van Loo G
Nat Genet; 2011 Aug; 43(9):908-12. PubMed ID: 21841782
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis.
Vande Walle L; Van Opdenbosch N; Jacques P; Fossoul A; Verheugen E; Vogel P; Beyaert R; Elewaut D; Kanneganti TD; van Loo G; Lamkanfi M
Nature; 2014 Aug; 512(7512):69-73. PubMed ID: 25043000
[TBL] [Abstract][Full Text] [Related]
3. A20 edits ubiquitin and autoimmune paradigms.
Martin F; Dixit VM
Nat Genet; 2011 Aug; 43(9):822-3. PubMed ID: 21874034
[No Abstract] [Full Text] [Related]
4. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
5. A20 deficiency causes spontaneous neuroinflammation in mice.
Guedes RP; Csizmadia E; Moll HP; Ma A; Ferran C; da Silva CG
J Neuroinflammation; 2014 Jul; 11():122. PubMed ID: 25026958
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.
Lippens S; Lefebvre S; Gilbert B; Sze M; Devos M; Verhelst K; Vereecke L; Mc Guire C; Guérin C; Vandenabeele P; Pasparakis M; Mikkola ML; Beyaert R; Declercq W; van Loo G
Cell Death Differ; 2011 Dec; 18(12):1845-53. PubMed ID: 21566665
[TBL] [Abstract][Full Text] [Related]
7. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
[TBL] [Abstract][Full Text] [Related]
8. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium fortuitum induces A20 expression that impairs macrophage inflammatory responses.
Lee GJ; Lee HM; Kim TS; Kim JK; Sohn KM; Jo EK
Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26940588
[TBL] [Abstract][Full Text] [Related]
10. A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection.
Maelfait J; Roose K; Bogaert P; Sze M; Saelens X; Pasparakis M; Carpentier I; van Loo G; Beyaert R
PLoS Pathog; 2012; 8(3):e1002570. PubMed ID: 22396652
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes.
Wolfrum S; Teupser D; Tan M; Chen KY; Breslow JL
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18601-6. PubMed ID: 18006655
[TBL] [Abstract][Full Text] [Related]
12. The deubiquitinase activity of A20 is dispensable for NF-κB signaling.
De A; Dainichi T; Rathinam CV; Ghosh S
EMBO Rep; 2014 Jul; 15(7):775-83. PubMed ID: 24878851
[TBL] [Abstract][Full Text] [Related]
13. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
15. A20 controls RANK-dependent osteoclast formation and bone physiology.
Martens A; Hertens P; Priem D; Rinotas V; Meletakos T; Gennadi M; Van Hove L; Louagie E; Coudenys J; De Muynck A; Gaublomme D; Sze M; van Hengel J; Catrysse L; Hoste E; Zajac JD; Davey RA; Van Hoorebeke L; Hochepied T; Bertrand MJM; Armaka M; Elewaut D; van Loo G
EMBO Rep; 2022 Dec; 23(12):e55233. PubMed ID: 36194667
[TBL] [Abstract][Full Text] [Related]
16. A20 promotes Brucella intracellular growth via inhibition of macrophage cell death and activation.
Wei P; Cui G; Lu Q; Yang L; Guan Z; Sun W; Zhao Y; Wang S; Peng Q
Vet Microbiol; 2015 Jan; 175(1):50-7. PubMed ID: 25433453
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
18. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
[TBL] [Abstract][Full Text] [Related]
19. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
20. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.
Vereecke L; Sze M; Mc Guire C; Rogiers B; Chu Y; Schmidt-Supprian M; Pasparakis M; Beyaert R; van Loo G
J Exp Med; 2010 Jul; 207(7):1513-23. PubMed ID: 20530205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]